Mitometh
- Generic Name
- Mitometh
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C15H12Cl4
- CAS Number
- 107465-03-2
- Unique Ingredient Identifier
- H8MTN7XVC2
- Background
Mitometh is under investigation for the treatment of Adenocarcinoma, Oropharyngeal Neoplasms, Nasopharyngeal Carcinoma, Non-small Cell Lung Cancer, and Stage IV Non-small Cell Lung Cancer, among others. Mitometh has been investigated for the treatment of Lung Neoplasms, Untreated Childhood Medulloblastoma, and Untreated Childhood Supratentorial Primitive Neu...
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath